Radiation Dermatitis: Prophylaxis and Management of Acute and Chronic Disease

The discussion focuses on the prophylaxis and management of acute and chronic radiation dermatitis, a common side effect of radiation therapy for certain cancers such as breast, head and neck, and anogenital cancers, affecting up to 90% of patients. The historical context reveals early radiation pioneers faced significant toxicities, underscoring the importance of understanding and managing these side effects today. The speaker emphasizes that dermatologists have a crucial role in addressing radiation dermatitis, which can severely impact quality of life. A survey of radiation oncologists revealed a reluctance to refer patients to dermatology, suggesting the need for improved collaboration and awareness of management strategies. Research indicates that Staphylococcus aureus colonization increases the severity of dermatitis; thus, chlorhexidine cleansers and mupirocin ointments have been tested for bacterial decolonization, showing promising results in clinical trials. Alternative approaches include using Methetel, a silicone-based film that offers protection during treatment, and topical corticosteroids, like mometasone, which can help mitigate dermatitis severity. For chronic radiation dermatitis, issues like fibrosis, telangiectasia, and secondary malignancies such as basal cell carcinoma warrant diligence in follow-up care and skin cancer screening. Ultimately, the talk advocates for a collaborative approach between dermatology and oncology to improve patient outcomes in managing radiation dermatitis.